GILD Feb 2025 65.000 call
| Previous close | 19.75 |
| Open | 19.75 |
| Bid | 20.10 |
| Ask | 21.00 |
| Strike | 65.00 |
| Expiry date | 2025-02-21 |
| Day's range | 19.75 - 19.75 |
| Contract range | N/A |
| Volume | |
| Open interest | 6 |
Insider MonkeyIs Gilead Sciences, Inc. (NASDAQ:GILD) The Most Popular Stock Among Mutual Funds According To Goldman Sachs?
We recently made a list of Goldman Sachs’ List Of Stocks Popular With Mutual Fund Managers: Top 20 Stocks. In this piece, we will look at where Gilead Sciences, Inc. (NASDAQ:GILD) ranks among the list of stocks that mutual funds are buying according to Goldman Sachs. As the fourth quarter of 2024 starts, the market […]
GuruFocus.comGilead Sciences Inc (GILD) Q2 2024 Earnings Call Highlights: Strong Growth in HIV and Oncology ...
Gilead Sciences Inc (GILD) reports robust financial performance with significant sales growth in key therapeutic areas and raises full-year guidance.
Business WireGilead Sciences to Release Third Quarter 2024 Financial Results on Wednesday, November 6, 2024
FOSTER CITY, Calif., October 09, 2024--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its third quarter 2024 financial results and guidance will be released on Wednesday, November 6, 2024, after the market closes. At 4:30 p.m. Eastern Time that day, Gilead’s management will host a webcast to discuss the company’s third quarter 2024 financial results and provide a business update.
